Mammary field cancerization: molecular evidence and clinical importance Christopher M. HeaphyJeffrey K. GriffithMarco Bisoffi Review 15 August 2009 Pages: 229 - 239
Cancer stem cells in breast cancer and metastasis Jessica C. LawsonGregory L. BlatchAdrienne L. Edkins Review 04 September 2009 Pages: 241 - 254
The efficacy of acupoint stimulation for the management of therapy-related adverse events in patients with breast cancer: a systematic review Li-Fen ChaoAnthony Lin ZhangSing Kai Lo Review 17 September 2009 Pages: 255 - 267
Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha Gregory E. WeitsmanWineeta WeebaddaLeigh C. Murphy Preclinical Study 21 October 2008 Pages: 269 - 279
Sodium phenylacetate inhibits the Ras/MAPK signaling pathway to induce reduction of the c-Raf-1 protein in human and canine breast cancer cells Manabu WatanabeNozomi MiyajimaSumio Sugano Preclinical Study 25 October 2008 Pages: 281 - 291
Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines Ling LaiLin YuanSteven Marc Hill Preclinical Study 04 November 2008 Pages: 293 - 305
Synergistic effect of bisphosphonate and docetaxel on the growth of bone metastasis in an animal model of established metastatic bone disease E. R. van BeekC. W. G. M. LowikS. E. Papapoulos Preclinical Study 07 November 2008 Pages: 307 - 313
Three-dimensional scapulothoracic motion following treatment for breast cancer Delva ShamleyRagavan SrinaganathanElaine Sugden Preclinical Study 09 November 2008 Pages: 315 - 322
The promoter C specific ERα isoform is associated with tamoxifen outcome in breast cancer Sandra AmaralWerner SchrothHiltrud Brauch Preclinical Study 15 November 2008 Pages: 323 - 331
Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas Helena WensmanHanna GöranssonEva Hellmén Preclinical Study 02 December 2008 Pages: 333 - 343
Discovery of candidate genes and pathways that may help explain fertility cycle stage dependent post-resection breast cancer outcome Eun-Young OhPatricia A. WoodWilliam J. M. Hrushesky Preclinical Study 03 December 2008 Pages: 345 - 359
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer John W. Smith IIKristi J. McIntyreJoyce A. O’Shaughnessy Clinical trial 21 May 2009 Pages: 361 - 367
The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer Meng-Fen WuS. G. HilsenbeckL. C. Friedman Clinical trial 03 June 2009 Pages: 369 - 375
Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients Orit FreedmanEitan AmirMark Clemons Clinical trial 24 June 2009 Pages: 377 - 383
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure E. MontagnaG. VialeM. Colleoni Clinical trial 27 June 2009 Pages: 385 - 394
Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study Neela GuhaMarilyn L. KwanBette J. Caan Epidemiology 17 February 2009 Pages: 395 - 405
Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk Rongxi YangBowang ChenBarbara Burwinkel Epidemiology 20 February 2009 Pages: 407 - 413
Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk Gordon FehringerNorman F. BoydHilmi Ozcelik Epidemiology 20 February 2009 Pages: 415 - 424
Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg Patrik VankrunkelsvenEliane KellenFrank Buntinx Epidemiology 24 February 2009 Pages: 425 - 432
